Markets

ONDS Rises on Israeli Drone Deal, Yet Valuation Looms Large

Ondas shares gained 2.4% to $9.535 following an Israeli drone contract, but the stock's valuation at 10.35x 2026 revenue remains a concern. Q2 earnings are due Thursday.

Daniel Marsh · · · 3 min read · 8 views
ONDS Rises on Israeli Drone Deal, Yet Valuation Looms Large
Mentioned in this article
ONDS $9.74 +4.62%

Ondas Holdings Inc. (NASDAQ:ONDS) saw its shares advance 2.4% to $9.535 in Tuesday trading, following the announcement of a new tactical drone contract with Israel's Ministry of Defense. The stock's gain underscores investor optimism about the company's expanding defense portfolio, but the market's valuation of Ondas remains a focal point.

With a market capitalization of $5.43 billion, Ondas is currently trading at 10.35 times the lower end of its 2026 revenue guidance of $525 million. This rich multiple suggests that investors are already pricing in a rapid conversion of the company's backlog and recent acquisitions into realized sales. The upcoming second-quarter financial results, scheduled for release before the market opens on Thursday, August 13, will be a critical test of whether that conversion is on track.

Digital Bat Program

The latest catalyst is the Digital Bat program, a multi-million-dollar initiative under which Ondas will lead the development and manufacturing of affordable tactical attack drones for the Israeli Defense Forces. The contract extends beyond the airframe, encompassing autonomy features, mission-specific software, command link systems, and production readiness.

Eric Brock, Chairman and CEO of Ondas, emphasized the strategic significance: "We are seeing a fundamental shift in defense priorities toward affordable autonomous systems that can be produced and deployed at a significant scale." Oshri Lugassy, co-CEO of Ondas Autonomous Systems, added, "Our approach is to develop the complete operational capability—not simply an individual drone."

Financial Metrics and Trading Activity

As of 15:31 EDT, Ondas shares were trading within a range of $9.20 to $9.54, with volume reaching 60.5 million shares, below the three-month average of 88.7 million. The stock remains 37.6% below its 52-week high of $15.28, though it has gained 117.0% over the past year.

The company's revenue trajectory has been dramatic. In the first quarter of 2026, Ondas reported revenue of $50.1 million, nearly matching the full-year 2025 figure of $50.7 million. The company's 2026 revenue guidance of at least $525 million represents a 935.5% increase over 2025. However, the operating loss widened to $42.7 million in Q1 2026, compared to $10.3 million in the prior-year period, and management has indicated that adjusted EBITDA losses are expected to peak in the second quarter before recovering. The autonomous-systems division targets adjusted EBITDA profitability by early 2027.

Acquisitions Drive Growth

Much of the growth is fueled by acquisitions. Ondas raised its revenue guidance to $390 million following its agreement to acquire DZYNE Technologies, a deal valued at approximately $875 million, consisting of $200 million in cash and 85 million Ondas shares (45 million of which are restricted for six months). The Cyberhawk acquisition, completed on Monday, was valued at roughly $125 million, with about 95% in cash and $5 million in seller rollover stock. Cyberhawk, which uses drones and AI for industrial inspections, is projected to generate over $45 million in revenue for its fiscal year ending March 2027, with 95% expected to be recurring. Cyberhawk's contribution is excluded from Ondas' 2026 guidance due to fiscal year differences.

Analyst Sentiment and Risks

Wall Street remains broadly positive, with a consensus rating of Moderate Buy and a median price target of $16.33, implying 71.3% upside from the current price. Recent actions include Roth Capital initiating coverage with a Buy and a $13 target, while Weiss Ratings downgraded the stock to Sell. Needham, Northland Securities, and H.C. Wainwright have all reaffirmed Buy ratings with targets ranging from $17 to $19.

However, risks abound. The company must integrate multiple recently acquired businesses, government contracts are subject to scheduling shifts, and the heavy use of stock-based consideration could lead to shareholder dilution. At 10.35 times sales, the market is pricing in flawless execution; any delays in backlog conversion could trigger a sharp correction.

All eyes will be on Thursday's Q2 report, which will reveal whether the company can sustain its ambitious growth narrative.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →